Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells
J. Sachsinger et al., Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells, CANCER RES, 61(14), 2001, pp. 5580-5586
In contrast to human primary fibroblasts, mouse embryonic fibroblasts have
telomerase activity, immortalize spontaneously in culture, and can be neopl
astic ally transformed by oncogenic insult. Ectopic expression of the human
telomerase catalytic subunit, human telomerase reverse transcriptase (hTER
T), in human primary cells allows both spontaneous immortalization and neop
lastic transformation by oncogenes, This suggests that telomerase activity,
as well as the fact that mouse telomeres are longer than human telomeres,
may explain some of the differences in cellular control between human and m
urine cells. Telomerase inhibition in immortal or transformed human cells u
sing dominant negative hTERT mutants leads to telomere shortening and cell
death. Here we study the effect of expression of a dominant negative mutant
of the catalytic subunit of mouse telomerase, mTERT-DN, in a murine kidney
tumor cell line, RenCa, whose telomeres are similar in length to human tel
omeres, After showing initial telomerase activity inhibition and telomere s
hortening, all clones expressing mTERT-DN reactivated telomerase and showed
normal viability, in contrast with that described for human cells. This ef
ficient telomerase reactivation coincided with a significant increase in th
e endogenous TERT mRNA levels in the presence of mTERT-DN expression. The r
esults presented here reveal the existence of fundamental differences in te
lomerase regulation between mice and man.